Chattopadhyay Sanat 4
4 · Merck & Co., Inc. · Filed May 1, 2025
Insider Transaction Report
Form 4
Chattopadhyay Sanat
Exe V-P & Pres. MMD
Transactions
- Award
Restricted Stock Unit
2025-04-29+7,791→ 7,791 totalFrom: 2026-04-29Exp: 2028-04-29→ Common Stock (7,791 underlying) - Award
Stock Option (Right to Buy)
2025-04-29+35,465→ 35,465 totalExercise: $84.71From: 2026-04-29Exp: 2035-04-28→ Common Stock (35,465 underlying)
Holdings
- 7,000(indirect: By GRAT February 2024)
Common Stock
- 74,289(indirect: By GRAT April 2025)
Common Stock
- 50,622(indirect: By GRAT May 2024)
Common Stock
- 53,417(indirect: By GRAT February 2025)
Common Stock
Footnotes (7)
- [F1]The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay February 2024 Grantor Retained Annuity Trust.
- [F2]The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay May 2024 Grantor Retained Annuity Trust.
- [F3]The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay February 2025 Grantor Retained Annuity Trust.
- [F4]The reporting person serves as the sole trustee of, and maintains complete investment control over, the Sanat Chattopadhyay April 2025 Grantor Retained Annuity Trust.
- [F5]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F6]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
- [F7]The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.